These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27163200)

  • 1. Participation of oleic acid in the formation of the aortic aneurysm in Marfan syndrome patients.
    Soto ME; Iturriaga Hernández AV; Guarner Lans V; Zuñiga-Muñoz A; Aranda Fraustro A; Velázquez Espejel R; Pérez-Torres I
    Prostaglandins Other Lipid Mediat; 2016 Mar; 123():46-55. PubMed ID: 27163200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.
    Gomez D; Al Haj Zen A; Borges LF; Philippe M; Gutierrez PS; Jondeau G; Michel JB; Vranckx R
    J Pathol; 2009 May; 218(1):131-42. PubMed ID: 19224541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
    Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
    Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.
    Nataatmadja M; West J; West M
    Circulation; 2006 Jul; 114(1 Suppl):I371-7. PubMed ID: 16820603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione system participation in thoracic aneurysms from patients with Marfan syndrome.
    Zúñiga-Muñoz AM; Pérez-Torres I; Guarner-Lans V; Núñez-Garrido E; Velázquez Espejel R; Huesca-Gómez C; Gamboa-Ávila R; Soto ME
    Vasa; 2017 May; 46(3):177-186. PubMed ID: 28173744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
    Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
    J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide in the Marfan vasculature: Friend or foe?
    Tehrani AY; Ciufolini MA; Bernatchez P
    Nitric Oxide; 2021 Nov; 116():27-34. PubMed ID: 34478846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome.
    Crosas-Molist E; Meirelles T; López-Luque J; Serra-Peinado C; Selva J; Caja L; Gorbenko Del Blanco D; Uriarte JJ; Bertran E; Mendizábal Y; Hernández V; García-Calero C; Busnadiego O; Condom E; Toral D; Castellà M; Forteza A; Navajas D; Sarri E; Rodríguez-Pascual F; Dietz HC; Fabregat I; Egea G
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):960-72. PubMed ID: 25593132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome.
    Oller J; Méndez-Barbero N; Ruiz EJ; Villahoz S; Renard M; Canelas LI; Briones AM; Alberca R; Lozano-Vidal N; Hurlé MA; Milewicz D; Evangelista A; Salaices M; Nistal JF; Jiménez-Borreguero LJ; De Backer J; Campanero MR; Redondo JM
    Nat Med; 2017 Feb; 23(2):200-212. PubMed ID: 28067899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive correlation between the dysregulation of transforming growth factor-β1 and aneurysmal pathological changes in patients with Marfan syndrome.
    Kim KL; Yang JH; Song SH; Kim JY; Jang SY; Kim JM; Kim JA; Sung KI; Kim YW; Suh YL; Suh W; Kim DK
    Circ J; 2013; 77(4):952-8. PubMed ID: 23291965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
    Howell DW; Popovic N; Metz RP; Wilson E
    Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome.
    Soto ME; Guarner-Lans V; Herrera-Morales KY; Pérez-Torres I
    Front Physiol; 2018; 9():77. PubMed ID: 29483877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
    Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
    J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.
    Hibender S; Franken R; van Roomen C; Ter Braake A; van der Made I; Schermer EE; Gunst Q; van den Hoff MJ; Lutgens E; Pinto YM; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; de Waard V
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1618-26. PubMed ID: 27283746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome.
    Wanga S; Hibender S; Ridwan Y; van Roomen C; Vos M; van der Made I; van Vliet N; Franken R; van Riel LA; Groenink M; Zwinderman AH; Mulder BJ; de Vries CJ; Essers J; de Waard V
    J Pathol; 2017 Nov; 243(3):294-306. PubMed ID: 28727149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.